Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal disease, and therapeutic agents have shown only modest efficacy. Epigenetic alterations contribute to the pathogenesis of IPF. The histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), has been approved for clinical use in cancer; however, its potential efficacy in modulating fibroblast survival and lung fibrosis has not been extensively investigated. We investigated the effects of SAHA on apoptosis of primary IPF myofibroblasts and on injury-induced lung fibrosis in a murine model. SAHA-induced apoptosis of IPF myofibroblasts, an effect that was mediated, at least in part, by upregulation of the pro-apoptotic gene Bak and downregulation of the anti-apoptotic gene Bcl-xL. Alterations in the expression of these apoptosis-related genes were associated with histone modifications and changes in DNA methylation. In addition to the expected higher levels of histone acetylation in treated cells, we also detected changes in other histone modifications, such as histone methylation. In a murine model of bleomycin-induced pulmonary fibrosis, SAHA-treated mice displayed decreased lung fibrosis and improved lung function compared to the bleomycin only group. These results suggest that histone deacetylase inhibitors may offer a new therapeutic strategy in IPF by modulating myofibroblast susceptibility to apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another reported hallmark of senescent fibroblasts, in idiopathic pulmonary fibrosis, is the enhanced expression of anti-apoptotic BCL2 family proteins such as BCL2L2, BCL2 and BCL2L1 along with reduced levels of the pro-apoptotic proteins BAK1 and BAX180,181.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [180]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 38 · Cited by 167
Metadata
- Authors
- Sanders, Y. Y., Hagood, J. S., Liu, H., Zhang, W., Ambalavanan, N., & Thannickal, V. J.
- Affiliations
- University of Alabama at Birmingham (US)
- University of California San Diego (US)
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2014-03-06
- Volume
- 43
- Issue
- 5
- Pages
- 1448-1458
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2140928316
- Cited by
- 167
- References
- 38
- Citations by year
- 2026: 17 · 2025: 14 · 2024: 17 · 2023: 12 · 2022: 11 · 2021: 17 · 2020: 16 · 2019: 11 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 15 · 2014: 4
- FWCI
- 11.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL082818, HL092906, HL082818, R01HL092906, P50HL107181, HL14470, R01HL067967)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, histone deacetylase inhibition, vorinostat, myofibroblast apoptosis, fibroblast survival, Bak, Bcl-xL, histone modifications, DNA methylation, histone acetylation, histone methylation, bleomycin-induced lung fibrosis, epigenetic therapy
- MeSH terms
- Vorinostat, Animals, Bleomycin, Cell Survival, Fibroblasts, Histone Deacetylases, Histones, Humans, Hydroxamic Acids, Lung, Mice, Inbred C57BL, Apoptosis, DNA Methylation, Cell Proliferation, Mice, Idiopathic Pulmonary Fibrosis, Histone Deacetylase Inhibitors, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. https://app.cochat.ai/papers/10.1183/09031936.00095113
- The paper
- Sanders, Y. Y., Hagood, J. S., Liu, H., Zhang, W., Ambalavanan, N., & Thannickal, V. J. (2014). Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice. European Respiratory Journal. https://doi.org/10.1183/09031936.00095113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.